Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Nov 03, 2023 05:21 pm ET
Mednow Restructuring to Meet Long-Term Needs of Stakeholders
Mednow Inc. (the “Company”) (TSXV: MNOW) (OTCQX: MDNWF) announced today that it and certain of its subsidiaries, including thirteen of its Canadian operating subsidiaries, 2716725 Ontario Inc., 10111132 Manitoba Ltd. (dba Mednow MB), Mednow Clinic Services Inc., Mednow East Inc., Mednow Medical Inc., Mednow Ontario Limited, Mednow Pharmacy AB Ltd., Mednow Operations Inc., Mednow Pharmacy Inc., Mednow Pharmacy MB Ltd., Mednow Pharmacy Services Inc., Mednow Technology Inc., and Mednow Virtual Care Ltd. have been placed into receivership by Order of the Supreme Court of British Colu
Nov 02, 2023 12:16 pm ET
Canadian Investment Regulatory Organization Trading Halt - MNOW
VANCOUVER, BC, Nov. 2, 2023 /CNW/ - The following issues have been halted by CIRO
Nov 01, 2023 09:05 pm ET
Mednow Announces Notice Received From Secured Creditor and Plan to Work on a Transitional Plan
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company"), Canada’s on-demand virtual pharmacy, announced today that it has received a notice of default, demand and intention to enforce security from its related secured creditor Alirey Corp. amounting to $3.23 million. Mednow intends to cooperate with secured creditor to facilitate a transitional plan.
Oct 31, 2023 01:26 am ET
Mednow Announces Corporate Update
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company") announces that Ali Reyhany has stepped down as CEO, President and Director. Felipe Campusano has also resigned as a Director, Treasurer and Secretary.
Oct 23, 2023 11:00 pm ET
Mednow Announces Closing of Senior Secured Convertible Debenture Financing by Mednow Management
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company"), Canada’s on-demand virtual pharmacy, is pleased to announce the closing of the previously announced non-brokered private placement offering of a secured convertible debenture (the “Convertible Debenture”), which was upsized from the previously announced gross proceeds of $400,000 to $850,000 (the “Offering”).
Oct 01, 2023 10:30 pm ET
Mednow Announces Corporate Update
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company") announces that Benjamin Ferdinand has stepped down as CFO to pursue other opportunities.
Sep 30, 2023 10:08 pm ET
Mednow Announces an Update on the Wind-Down of a Subsidiary
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF), Canada’s on-demand virtual pharmacy, announced today that Infusicare Inc. (“Infusicare”) is no longer in operation and that it is in discussions with its bank on its outstanding debt.
Sep 18, 2023 11:30 pm ET
Mednow Announces the Execution of Cost Reductions Through the Wind-Down of a Subsidiary
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF), Canada’s on-demand virtual pharmacy, announced today that Infusicare Inc. (“Infusicare”) has permanently ceased ordinary course business operations.
Sep 11, 2023 07:00 am ET
Mednow Announces Senior Secured Convertible Debenture Financing by Mednow Management
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company"), Canada’s on-demand virtual pharmacy, is pleased to announce a private placement offering of a secured convertible debenture (the “Convertible Debenture”) for gross proceeds of $400,000 (the “Offering”).
Sep 04, 2023 08:00 pm ET
Mednow Announces Board Member Resignations
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company") announces that Kia Besharat and Mahdi Shams have stepped down as directors of the Company to pursue other opportunities.
Aug 29, 2023 09:00 pm ET
Mednow Announces the Execution of Cost Reductions Through the Wind-Down of Two Subsidiaries
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF), Canada’s on-demand virtual pharmacy, announced that its previously announced wind-down of London Pharmacare Inc. (“LCP”) has concluded with the bankruptcy of LCP.
Aug 01, 2023 07:00 am ET
Mednow Announces Closing of Senior Secured Convertible Debenture Financing by Mednow Management
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company"), Canada’s on-demand virtual pharmacy, is pleased to announce the closing of the previously announced non-brokered private placement offering of a secured convertible debenture (the “Convertible Debenture”) for gross proceeds of $400,000 (the “Offering”).
Jul 28, 2023 01:11 am ET
Mednow Announces Senior Secured Convertible Debenture Financing by Mednow Management
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company"), Canada’s on-demand virtual pharmacy, is pleased to announce a private placement offering of a secured convertible debenture (the “Convertible Debenture”) for gross proceeds of $400,000 (the “Offering”).
Jun 30, 2023 07:00 am ET
Mednow Achieves Record Q3 2023 Financial Results with Quarterly Revenue of $12.8 Million; 13% Q/Q Revenue Growth and 105% Y/Y Revenue Growth; Continues to Focus on Core Virtual Pharmacy Growth and Cos
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce it has released its financial results for the period ending April 30, 2023 (“Q3 2023”). Mednow’s Financial Statements and Management, Discussion & Analysis are available on sedar.com and on the Company’s website,
Jun 28, 2023 07:00 am ET
Mednow to Host Quarterly Conference Call on Friday, June 30, 2023, at 8:30am EST on its Third-Quarter 2023 Financial Results
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting its quarterly conference call on Friday, June 30, 2023 at 8:30am EST. The conference call will cover its third-quarter 2023 financial results.
Jun 14, 2023 08:05 am ET
Mednow Announces Pharmacy Partnership agreement with ServicePlus, a national total rewards platform operated by PIPSC (Professional Institute of the Public Service of Canada)
Mednow Inc. (“Mednow” or the “Company) (TSXV: MNOW) (OTCQX: MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has executed a Preferred Pharmacy Agreement with ServicePlus, a leading provider of Member Benefit and rewards services. The agreement allows ServicePlus members to leverage enhanced services and preferred pricing from Mednow digital pharmacy and healthcare platform to its clients and plan members.
Jun 06, 2023 07:00 am ET
Mednow Provides Business Strategy and Virtual Pharmacy Growth Update
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF), Canada's leading on-demand virtual pharmacy, is excited to provide a comprehensive update on its business strategy and early growth in the virtual pharmacy sector. With a renewed focus on its core offerings of technology-enabled virtual pharmacy and virtual care experiences, Mednow is executing on its plan to modernize the $47 Billion pharmacy industry.(1) This update outlines the key areas of our strategic plan and showcases the early success of our disruptive virtual pharmacy experience.
May 29, 2023 12:00 pm ET
Mednow Inc. to Present at LD Micro Invitational XIII
Mednow Inc (TSXV: MNOW) (OTCQX:MDNWF) – Mednow announced today that it will be presenting at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, California on June 6th-8th, 2023. The event is expected to feature 150+ companies, presenting in half-hour increments, as well as private 1:1 meetings.
May 26, 2023 10:26 am ET
Mednow Inc. to Present at the Gravitas’ 4th Los Angeles Summit
Mednow Inc (TSXV: MNOW) (OTCQX:MDNWF) – Mednow is pleased to announce it will be presenting at Gravitas’ 4th Los Angeles Summit, which will be taking place at The Beverly Hills Hotel from Sunday, June 4th to Tuesday, June 6th, 2023, in Beverly Hills, California.
May 24, 2023 07:00 am ET
Reformulary Group Inc. and Mednow Inc. Partner to Advance the Mission of Making Medications More Transparent, More Accessible, and More Affordable for All Canadians
Mednow Inc (TSXV: MNOW) (OTCQX:MDNWF) is proud to announce today that Reformulary Group Inc. has chosen Mednow as a preferred digital pharmacy, helping optimize the member experience of close to 300,000 and growing, subscribed members. Reformulary Group built and manages The Reformulary®, its proprietary drug list (formulary) becoming the most recognized independent formulary in Canada, along with the award-winning Drugfinder® search tool. Partnering with the Reformulary team, like-minded healthcare professionals, Mednow will offer managed formularies powered by Reformula
May 17, 2023 07:00 am ET
Mednow Announces Partnership With Medcan Health Management Inc. to Deliver Collaborative, Interdisciplinary Healthcare
Mednow Inc (TSXV: MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy has been named the preferred virtual pharmacy partner for Medcan Health Management Inc. (“Medcan”) and its valued clients.
May 16, 2023 08:43 pm ET
Mednow Announces a Partnership with Next Level Benefits to Offer its Services to their Clients and Plan Members; Announces the Ongoing Process to Wind-Down Select Subsidiaries
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has executed a Preferred Pharmacy Agreement with Next Level Benefits, a leading provider of Employee Benefit and Retirement Programs (the “Agreement”) (“Next Level Benefits”). The agreement allows Next Level Benefits with the ability to provide Mednow's digital pharmacy and healthcare platform to its clients and plan members.
May 15, 2023 09:18 am ET
Mednow Announces Closing of Prospectus Supplement Financing Led by Gravitas Securities and Concurrent Non-brokered Private Placement for Aggregate Proceeds of $1.1 Million
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company"), Canada’s on-demand virtual pharmacy, is pleased to announce that further to the Company’s news releases dated April 24, 2023, May 9, 2023 and May 10, 2023, the Company has closed its previously announced "commercially reasonable efforts" offering by way of prospectus supplement (the “Offering”). Pursuant to the Offering, the Company issued 1,945,415 units of the Company (“Units”) at a price of $0.27 per Unit (the “Unit Price”) for aggregate gross proceeds of approximately $525,262. The Offer
May 11, 2023 09:00 am ET
Mednow Announces Filing of Prospectus Supplement
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company"), Canada’s on-demand virtual pharmacy, is pleased to announce that further to the Company’s news releases dated April 24, 2023 and May 9, 2023, the Company has entered into an agency agreement dated May 9, 2023 (the "Agency Agreement") with Gravitas Securities Inc. (the "Agent"). Pursuant to the Agency Agreement, the Company proposes to complete a "commercially reasonable efforts" offering by way of prospectus supplement to the Company’s base shelf prospectus dated July 15, 2022 (the “Offering
May 09, 2023 10:00 pm ET
Mednow Announces Amendment to Terms of Prospectus Supplement Offering
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF), Canada’s on-demand virtual pharmacy, announced today that further to its news release dated April 24, 2023, the Company has amended the terms of its offering by way of prospectus supplement for proceeds of up to $1,000,000 (the “Offering”) led by Gravitas Securities Inc. (the “Agent”). Pursuant to the Offering, the Company has engaged the Agent to offer on a “commercially reasonable efforts” basis up to 3,703,704 units of the Company (“Units”) at a price of $0.27 per Unit (the “Unit Price”). The Company has agreed to g
May 09, 2023 09:57 am ET
Mednow Announces the Execution of Cost Reductions Through the Wind-Down of Two Subsidiaries
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF), Canada’s on-demand virtual pharmacy, announced today that Liver Care Canada Inc. has permanently ceased ordinary course business operations. London Pharmacare Inc. will commence its closure in the near-future.
May 02, 2023 10:00 pm ET
Mednow Announces Cost Reductions Through Efficiencies and Streamlining of Business Lines
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF), Canada’s on-demand virtual pharmacy, announced today that it is executing on cost reduction measures and operational streamlining to focus on operating a more efficient business.
Apr 26, 2023 07:00 am ET
Mednow Releases Multiple Updates to Its IOS, Android and Web Based Applications, Including Pharmacist Led In-App Prescribing, Clinical Services Flows, and Single Sign-On for Seamless Patient and Partn
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF), Canada’s on-demand virtual pharmacy is pleased to release a suite of new features for its Web, iOS, and Android virtual pharmacy applications. As of January 1st, pharmacists in Ontario were able to better support patients by assessing and prescribing treatment for 13 minor conditions. These conditions include hives, cold sores, urinary tract infections and pink eye, among others. These services are available for patients with a valid Ontario health card. There is no out-of-pocket charge for patients as this initiative is publicly funded. Mednow users vi
Apr 24, 2023 04:35 pm ET
IIROC Trading Resumption - MNOW
VANCOUVER, BC, April 24, 2023 /CNW/ - Trading resumes in:
Apr 24, 2023 04:08 pm ET
Mednow Announces Financing by Way of Prospectus Supplement for Proceeds of up to $1,000,000 Led by Gravitas Securities
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company"), Canada’s on-demand virtual pharmacy, is pleased to announce that it has engaged Gravitas Securities Inc. (the “Agent”) to offer on a "commercially reasonable efforts" basis (the “Offering”) up to 2,325,581 units of the Company (“Units”) at a price of $0.43 per Unit (the “Unit Price”) for aggregate gross proceeds of up to $1,000,000 (the “Proceeds”). The Company has agreed to grant the Agent an option to increase the size of the Offering by up to 15% (the “Over-
Apr 24, 2023 03:16 pm ET
IIROC Trading Halt - MNOW
VANCOUVER, BC, April 24, 2023 /CNW/ - The following issues have been halted by IIROC:
Apr 24, 2023 07:00 am ET
Mednow announces PBAS partnership.
Mednow Inc. (“Mednow” or the “Company”) (TSXV: MNOW) (OTCQX: MDNWF), Canada’s on-demand virtual pharmacy, is announcing a new partnership with Prudent Benefits Administration Services, Inc. (“PBAS”), a leading third-party administrator that delivers comprehensive benefits administration services to over 200,000 Canadians. The partnership will provide Mednow's digital pharmacy and healthcare platform to participating PBAS clients and their members, part of Mednow's efforts to expand its Mednow for Business offering to large groups seeking a cost-effective and patient- centred healthcare platfor
Mar 31, 2023 07:00 am ET
Mednow Achieves Record Q2 2023 Financial Results with Quarterly Revenue of $11.3 Million; 17% Q/Q Revenue Growth and 466% Y/Y Revenue Growth; Adjusted EBITDA Improved 32% Y/Y; and Cash Flow from Opera
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce it has released its financial results for the period ending January 31, 2023 (“Q2 2023”). Mednow’s Financial Statements and Management, Discussion & Analysis are available on sedar.com and on the Company’s website,
Mar 28, 2023 07:00 am ET
Mednow to Host Quarterly Conference Call on Friday, March 31, 2023, at 8:30am EST on its Second-Quarter 2023 Financial Results
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting its quarterly conference call on Friday, March 31, 2023 at 8:30am EST. The conference call will cover its second-quarter 2023 financial results.
Mar 02, 2023 06:57 am ET
PARVIS INVEST INC. AND GRAVITAS II CAPITAL CORP. RECEIVE CONDITIONAL APPROVAL OF REVERSE TAKEOVER TRANSACTION AND FILE FILING STATEMENT
VANCOUVER, BC, March 2, 2023 /CNW/ - Gravitas II Capital Corp. ("Gravitas II") (TSXV: GII.P) and Parvis Invest Inc. ("Parvis") are pleased to announce that, in connection with their previously announced proposed business combination (the "Transaction") as described in Gravitas II's news releases dated November 3, 2022 and August 29, 2022, the TSX Venture Exchange Inc. (the "Exchange") has conditionally approved the Transaction and the listing of the common shares of Gravitas II, following closing of the Transaction (the "Resulting Issuer"). The Transaction is expected to close on March 3, 20
Feb 24, 2023 07:00 am ET
Mednow Inc. to Present at the Gravitas 6th Annual Growth Conference
Mednow Inc. (TSXV: MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce it will be presenting at the Gravitas 6th Annual Growth Conference taking place at the Fairmont Pacific Rim Hotel on Thursday, March 2nd, 2023, in Vancouver, British Columbia.
Feb 21, 2023 07:00 am ET
Mednow releases Caregiver feature suite in its latest product update for the company’s web, IOS and Android applications; Mednow announces completion of Convertible Debenture Financing
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF), Canada’s on-demand virtual pharmacy has launched its largest technology release to-date.
Feb 08, 2023 07:00 am ET
Mednow Announces Closing of First Tranche of Senior Secured Convertible Debenture Financing Led by Mednow Management
Ali Reyhany, CEO and Co-Founder, invested $1,800,000 as part of the Offering. This investment, when combined with previous investments he has made directly or indirectly in Mednow’s stock, cumulatively represents over $2,245,000 since the company’s initial public offering in March 2021.
Feb 02, 2023 07:00 am ET
Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom
Mednow Inc. (“Mednow” or the “Company”) (TSXV: MNOW) (OTCQX: MDNWF) announced today the launch of its enhanced Virtual Diabetes Management program, an end-to-end digital diabetes management solution, to enable convenient on-demand access to Dexcom G6 (NASDAQ: DXCM) real-time continuous glucose monitoring (rtCGM) supplies and personalized diabetes care services.
Jan 23, 2023 07:00 am ET
Mednow Supports Expanded Scope of Practice for Ontario Pharmacists
Mednow Inc (TSXV: MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy is supportive of the new expanded scope of practice for Ontario pharmacists.
Jan 18, 2023 03:45 pm ET
The Power Play by The Market Herald Releases New Interviews with Mednow, Silver Bullet Mines, Maple Gold Mines, POET, Global Battery Metals, Stillwater Critical Minerals, and Fission Uranium Discussin
VANCOUVER, BC / ACCESSWIRE / January 18, 2023 / The Power Play by The Market Herald has announced the release of new interviews with Mednow, Silver Bullet Mines, Maple Gold Mines, POET, Global Battery Metals, Stillwater Critical Minerals, and Fission Uranium discussing their latest news.
Jan 18, 2023 07:00 am ET
Mednow Achieves Record Q1 2023 Financial Results with Quarterly Revenue of $9.7 Million; 35% Q/Q Revenue Growth and 1,300% Y/Y Revenue Growth; Costs Down 30% and Cash Flow from Operations Improved by
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce it has released its financial results for the period ending October 31, 2022 (“Q1 2023”). Mednow’s Financial Statements and Management, Discussion & Analysis are available on sedar.com and on the Company’s website,
Jan 12, 2023 07:00 am ET
Mednow Digital Pharmacy Integrates Pharmacist House Calls Into Medvisit, Its Doctor Home Visit Company, and Announces Amended Terms and Upsize of Senior Secured Convertible Debenture Financing
Mednow Inc (TSXV:MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy has expanded its suite of services to its at-home Medvisit and other patients.
Jan 09, 2023 07:00 am ET
Mednow to Host Quarterly Conference Call on Wednesday January 18, 2023, at 8:30am EST on its First-Quarter 2023 Financial Results
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting its quarterly conference call on Wednesday January 18, 2023 at 8:30am EST. The conference call will cover its first-quarter 2023 financial results.
Jan 04, 2023 07:00 am ET
Mednow Enters Into National Distribution and Preferred Pharmacy Network (PPN) Agreement With Care Pharmacies; Announces Grant of Management Cease Trade Order
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW) (OTCQX:MDNWF) Canada’s on-demand pharmacy, enhances its national virtual pharmacy offering by partnering with Care Pharmacies.
Dec 15, 2022 06:00 pm ET
Mednow Announces Filing of Application for Management Cease Trade Order and Change of Auditor
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company") announces today that it will likely miss its filing deadline of December 30, 2022 to file unaudited interim financial statements and accompanying management's discussion and analysis and related CEO and CFO certificates for the period ended October 31, 2022 (collectively, the "Interim Filings"), as required under applicable Canadian securities laws.
Nov 29, 2022 07:00 am ET
Mednow Achieves Record Q4 2022 Financial Results with +11% Q/Q Revenue Growth and 5,700% Y/Y Revenue Growth
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce it has released its financial results for the period ending July 31th, 2022 (“Q4 2022”). Mednow’s Financial Statements and Management, Discussion & Analysis are available on sedar.com and on the Company’s website,
Nov 25, 2022 07:00 am ET
Mednow to Host Quarterly Conference Call on Tuesday November 29, 2022, at 8:30am EST on its Fourth-Quarter 2022 Financial Results
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting its quarterly conference call on Tuesday November 29, 2022 at 8:30am EST. The conference call will cover its fourth-quarter 2022 financial results.
Nov 08, 2022 07:00 am ET
Mednow Opens Alberta Pharmacy Location
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW) (OTCQX:MDNWF) Canada’s on-demand pharmacy, is officially open to serve patients in Alberta.
Nov 07, 2022 07:00 am ET
Mednow Announces Senior Secured Convertible Debenture Financing of up to $3,000,000 Led by Gravitas Securities
Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company"), Canada’s on-demand virtual pharmacy, is pleased to announce that it has engaged Gravitas Securities Inc. (the “Agent”) to offer on a "commercially reasonable efforts" basis senior secured convertible debentures of the Company (each, a “Convertible Debenture”) at a price of $1,000 per Convertible Debenture for gross proceeds to the Company of up to $3,000,000 (the “Offering”). The Company has further agreed to grant the Agent an option to increase the size of the Offering by up to 15% (the “
Oct 20, 2022 07:00 am ET
Mednow to Present at the LD Micro Main Event XV
Toronto, Ontario--(Newsfile Corp. - October 20, 2022) - Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF), Canada's on-demand virtual pharmacy, will be presenting at the 15th annual LD Micro Invitational on Thursday, October 27, 2022, at 9:00 am PT (12:00 pm ET) at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Ali Reyhany, Chief Executive Officer and Co-Founder, will be giving the presentation.
Oct 17, 2022 07:00 am ET
An Open Letter to Mednow Investors
Mednow Inc (TSXV: MNOW) (OTCQX:MDNWF) — Mednow Co-Founder and CEO Ali Reyhany shared an open letter with investors detailing key achievements and milestones over the past 18 months as well as important context on the market overall and as it pertains to Mednow specifically. The content of that letter appears below.
Oct 06, 2022 07:00 am ET
Aya chooses Mednow as Preferred Pharmacy Partner
Mednow Inc. (TSXV: MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy, has been named the Preferred Pharmacy Partner for Aya members.
Sep 12, 2022 07:00 am ET
Mednow to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy, will participate at the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022.
Aug 24, 2022 07:00 am ET
Mednow Signs Franchise Agreement to Open Quebec Pharmacy
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW) (OTCQX:MDNWF) Canada’s on-demand virtual pharmacy, is officially open to serve patients in Quebec. This newest Mednow location will serve as the pharmacy distribution center (the “Quebec Pharmacy Distribution Center”) for all Mednow customers in Quebec, offering Mednow’s fast, free prescription delivery and deep commitment to holistic, pharmacist-led patient care.
Jun 29, 2022 07:00 am ET
Mednow’s Liver Care Canada Partners With HepCURE With the Goal of Eliminating Hepatitis C in Canada by 2030
Liver Care Canada (a subsidiary of Mednow Inc.) (TSXV: MNOW) (OTCQX:MDNWF), is pleased to announce that it has entered into a partnership agreement with HepCURE, a non-profit company and one of Canada’s leading hepatitis C screening and treatment providers, to achieve the goal of eliminating hepatitis C in Canada by 2030.
Jun 15, 2022 07:00 am ET
Mednow Beats Guidance & Achieves Record Q3 2022 Financial Results with 225% Q/Q Revenue Growth and 4,800% Y/Y Revenue Growth and Appoints Ali Reyhany CEO
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce it has released its financial results for the period ending April 30th, 2022 (“Q3 2022”). Mednow’s Financial Statements and Management, Discussion & Analysis are available on sedar.com and on the Company’s website,
Jun 10, 2022 07:00 am ET
Mednow to Present at Gravitas’ 3rd Los Angeles Summit
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce it will be presenting at Gravitas Securities Inc.’s (“Gravitas”) 3rd Los Angeles Summit, which will be taking place at the Beverly Hills Hotel from June 21st to June 24th, 2022, in Beverly Hills, California.
Jun 08, 2022 07:00 am ET
Mednow to Host Quarterly Conference Call on Wednesday June 15, 2022, at 8:30am EST on its Third-Quarter 2022 Financial Results
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting its quarterly conference call on Wednesday June 15, 2022 at 8:30am EST. The conference call will cover its third-quarter 2022 financial results.
May 27, 2022 07:00 am ET
Mednow Partners With Curv Health to Provide Canadians With a Virtual Integrated Diabetes Management Program
Mednow Inc. (“Mednow”) (TSXV: MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce a strategic partnership with Curv Health, a digital health company that provides low-cost health services to tens of thousands of employees across Canada. Curv Health and Mednow’s care teams have partnered on an integrated care program for type 1 and type 2 diabet
May 10, 2022 07:00 am ET
Sidoti May Virtual Micro Cap Investor Conference
NEW YORK, NY / ACCESSWIRE / May 10, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day May Micro Cap Virtual Conference taking place Wednesday and Thursday, May 11th-12th, 2022. The links can also be found at www.sidoticonference.com/events.
May 09, 2022 07:00 am ET
Mednow Announces the Graduation to OTCQX Trading, to Expand Access to U.S. Investors
Mednow Inc. (“Mednow’' or the “Company”) (TSXV: MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce that its common shares are now trading on the OTCQX Best Market under the ticker symbol of MDNWF. The OTCQX Best Market is the highest market tier of OTC Markets, which operated markets on which 12,000 U.S. and global securities trade. Trading on OTCQX will enhance the visibility and accessibility of the Company to U.S. investors. Mednow's common shares will continue to trade on the TSX Venture Exchange under the symbol MNOW.
Apr 26, 2022 03:25 pm ET
The Power Play by The Market Herald Releases Interviews with Mednow and Tocvan Ventures
VANCOUVER, BC / ACCESSWIRE / April 26, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Mednow and Tocvan Ventures on their latest news.
Apr 26, 2022 07:00 am ET
Mednow Provides Revenue Guidance on Fiscal Q3 2022, a Projected Record C$5 - C$5.5 Million in Quarterly Revenue, Q/Q Growth of Approx. 175%
Mednow Inc. (“Mednow’' or the “Company”) (TSXV: MNOW) (OTCQB:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to provide a corporate update on its upcoming fiscal Q3 2022 quarterly earnings, which will be released in June 2022.
Apr 18, 2022 07:00 am ET
Mednow.ca Launches a Licenced Pharmacy in Manitoba; ‘Pharmacy of the Future’ Designed to Improve Health Outcomes Through Unlimited Pharmacist Consults, and More
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, launched today in Winnipeg, to serve Manitoba. This Canadian health tech company, founded by pharmacists, offers unlimited virtual pharmacist consults, fast, free medication delivery, and advanced technology to help address
Apr 01, 2022 07:00 am ET
Mednow Closes Previously Announced Acquisition of Pharmacy in Toronto
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company has completed the acquisition (the "Acquisition"), previously announced on March 7, 2022, of all of the issued and outstanding voting shares of Mednow Pharmacy Inc. (“Mednow East”), for an aggregate cash payment of approximately C$65,578 and the Company’s agreement to convert approximately C$1,374,422 owed by Mednow East to the Company pursuant to a pharmacy agreement dated September 15, 2020, as amended October 30, 2020 (the “Pharmacy Agr
Mar 30, 2022 07:00 am ET
Mednow to Attend DC Finance’s Montreal Conference on April 5th, 2022
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, will be participating in DC Finance’s Montreal Family Office and High Net Worth Individuals Conference on Tuesday April 5, 2022.
Mar 28, 2022 07:00 am ET
Mednow to Attend Lytham Partners Spring 2022 Investor Conference
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, will be attending Lytham Partners’ Virtual Spring 2022 Investor Conference from April 4-7, 2022.
Mar 23, 2022 03:15 pm ET
The Power Play by The Market Herald Releases Interviews With Talon Metals, Mednow, Nextech AR, Fabled Copper, and QuestEx
VANCOUVER, BC / ACCESSWIRE / March 23, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Talon Metals, Mednow, Nextech AR, Fabled Copper, and QuestEx on their latest news.
Mar 23, 2022 07:00 am ET
Mednow Achieves Record Q2 2022 Financial Results with 230% Q/Q Revenue Growth and 1,400% Y/Y Revenue Growth
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce it has released its financial results for the period ending January 31st, 2022 (“Q2 2022”). Mednow’s Financial Statements and Management, Discussion & Analysis are available on sedar.com and on the Company’s website,
Mar 22, 2022 07:00 am ET
Mednow to Attend 8th Annual AlphaNorth Capital Conference
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, will attend the eighth annual AlphaNorth Capital Conference from March 25-27, 2022.
Mar 16, 2022 07:00 am ET
Mednow Launches Personalized Supplement Program
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW; OTCQB:MDNWF), Canada’s on-demand virtual pharmacy, is proud to announce it has launched Total Health by Mednow which strives to provide consumers focused on preventive health, with science and evidence-based personalized supplement plans. With the launch of
Mar 15, 2022 07:00 am ET
Mednow to Host Quarterly Conference Call on Wednesday March 23, 2022, at 8:30am EDT on its Second-Quarter 2022 Financial Results and a Corporate Update
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting its quarterly conference call on Wednesday March 23, 2022 at 8:30am EDT. The conference call will cover its second-quarter 2022 financial results, and a corporate update.
Mar 08, 2022 04:01 pm ET
Mednow Named Great Place to Work® 2022 Best Workplaces For Women
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW; OTCQB:MDNWF), Canada’s on-demand virtual pharmacy, is proud to announce that Mednow has been named on the Great Place to Work® 2022 Best Workplaces for Women list.
Mar 07, 2022 07:00 am ET
Mednow Enters Into Agreement to Acquire Mednow East Inc. in Ontario
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW; OTCQB:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has entered into a share purchase agreement (the “Share Purchase Agreement”) on March 4, 2021 with Mednow East Inc. (“Mednow East”) and the shareholders of Mednow East, pursuant to which the Company shall acquire all of the issued and outstanding shares (the “Shares”) of Mednow East, in consideration for an aggregate cash payment of approximately C$65,578 and the Company’s agreement to convert approximately C$1,374,422
Feb 24, 2022 07:00 am ET
Mednow Provides Corporate Update on Progress and 2022 and 2023 Financial Forecasts
Mednow Inc. (“Mednow’' or the “Company”) (TSXV: MNOW), Canada’s on-demand virtual pharmacy, is pleased to provide a corporate update on its yearly progress.
Feb 23, 2022 07:00 am ET
Mednow Announces Amendment to Agreement to Acquire London Pharmacare Inc. and Completion of the Acquisitions of London Pharmacare Inc. and Liver Care Canada Inc.
Mednow Inc. (“Mednow” or the “Company”) (TSXV: MNOW), Canada’s on-demand virtual pharmacy, announces that, further to its news release dated December 21, 2021, the Company has entered into an amending agreement (the “Amending Agreement”) in respect of the share purchase agreement dated December 20, 2021 with London Pharmacare Inc. ("London Pharmacare") and the shareholders of London Pharmacare. Pursuant to the Amending Agreement, the consideration payable to acquire all of the issued and outstanding shares of London Pharmacare was in the aggregate decreased to consi
Jan 26, 2022 07:00 am ET
Mednow Awarded 2022 Best Workplace™ - Start-ups
Mednow Inc. (“Mednow” or the “Company”) (TSXV: MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has been recognized as a 2022 Best WorkplaceTM – Start-ups. To be eligible for this list, an organization must be “Great Place to Work – Certified” in the past year, self-identify as a Start-up, have been in business less than 10 years and have not yet reached the scale-up phase. There are several key metrics that are assessed before being awarded this recognition including culture, diversity, compensation, and benefits, in addition to in-d
Jan 14, 2022 07:00 am ET
Mednow Announces Partnership With PACE Consulting Benefits and Pensions Ltd. and PACE Consulting MGA Services Inc. to Offer Its Services to Benefit Plan Members
Mednow Inc. (“Mednow” or the “Company”) (TSXV: MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has partnered with PACE Consulting Benefits and Pensions Ltd. and PACE Consulting MGA Services Inc. (“PACE”) pursuant to a marketing services agreement (the “Agreement”). The Agreement allows PACE to market Mednow’s digital pharmacy and healthcare platform to its network of plan members.
Dec 22, 2021 07:00 am ET
Mednow Reports Q1 2022 Financial Results and Operational Milestones
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce it has released its financial results for the period ending October 31st, 2021 (“Q1 2022”). Mednow’s Financial Statements and Management, Discussion & Analysis are available on sedar.com and on the Company’s website,
Dec 21, 2021 07:49 am ET
IIROC Trading Resumption - MNOW
VANCOUVER, BC, Dec. 21, 2021 /CNW/ - Trading resumes in:
Dec 21, 2021 07:00 am ET
Mednow Enters into Agreement to Acquire Liver Care Canada Inc. and London Pharmacare Inc.
Mednow Inc. (“Mednow” or the “Company”) (TSXV: MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company has entered into the following two non-arm’s length party transactions pursuant to: (1) a share purchase agreement dated December 20th, 2021 with Liver Care Canada Inc. ("Liver Care Canada") and the shareholders of Liver Care Canada pursuant to which the Company shall acquire, directly or through an affiliate, all of the issued and outstanding shares of Liver Care Canada (the "Liver Care Shares") for an initial cash payment in the
Dec 20, 2021 03:46 pm ET
IIROC Trading Halt - MNOW
VANCOUVER, BC, Dec. 20, 2021 /CNW/ - The following issues have been halted by IIROC:
Dec 20, 2021 07:00 am ET
Mednow to Host Quarterly Conference Call on Wednesday December 22, 2021, at 8:30am EST on its First-Quarter 2022 Financial Results and a Corporate Update
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting its quarterly conference call on Wednesday December 22, 2021 at 8:30am EST. The conference call will cover its first-quarter 2022 financial results, and an update.
Dec 13, 2021 07:00 am ET
Mednow Closes Acquisition of Infusicare Pharmacy
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce that further to its press release dated November 18, 2021, it has closed the acquisition of Infusicare Canada Inc. (“Infusicare”) for a cash payment of C$1.85M.
Dec 07, 2021 04:30 pm ET
Sidoti December Micro Cap Virtual Conference
Presentation Times Released for 75+ Presenting Companies
Nov 24, 2021 04:00 pm ET
The Power Play by The Market Herald Releases New Interviews with Algernon Pharmaceuticals, Better Plant Sciences, and Mednow Inc. Discussing Their Latest News
VANCOUVER, BC / ACCESSWIRE / November 24, 2021 / The Power Play by The Market Herald releases new interviews with Algernon Pharmaceuticals, Better Plant Sciences and Mednow Inc. discussing their latest news.
Nov 24, 2021 07:00 am ET
Mednow Announces Strategic Investment in U.S. Virtual Care Provider Doko Medical Inc.
Mednow Inc. (“Mednow” or the “Company”) (TSXV: MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has closed a C$500,000 investment in Doko Medical Inc. (“Doko Medical”) by way of convertible debenture (the “Doko Investment”), for a 2.8% equity interest in Doko Medical at a C$17.5M pre-money valuation.
Nov 18, 2021 07:39 am ET
IIROC Trading Resumption - MNOW
VANCOUVER, BC, Nov. 18, 2021 /CNW/ - Trading resumes in:
Nov 18, 2021 07:00 am ET
Mednow Enters Into Agreement to Acquire Infusicare Canada Inc.
Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company has entered into a share purchase agreement (the “Share Purchase Agreement”) on November 18th, 2021 with Infusicare Canada Inc. (“Infusicare”) and the shareholders of Infusicare, pursuant to which the Company shall acquire all of the issued and outstanding shares (the “Shares”) of Infusicare, in consideration for an aggregate cash payment of approximately C$1.85M.
Nov 17, 2021 03:35 pm ET
IIROC Trading Halt - MNOW
VANCOUVER, BC, Nov. 17, 2021 /CNW/ - The following issues have been halted by IIROC:
Nov 12, 2021 07:00 am ET
Mednow Acquires the License and Exclusive Canadian Distribution Rights for Genetic Testing Technology from TruDiagnostic™
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW; OTCQB:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce the Company has signed a two-year investment agreement (the “Investment Agreement”) to acquire the License and Exclusive Distribution Rights of TruDiagnostic™ in Canada. Pursuant to the Investment Agreement, Mednow paid a one-time licensing fee of US$150,000 to TruDiagnostic™ for access and use of the TruDiagnostic™ Technology and TruDiagnostic™ Platform for the development, importation, use, marketing, sale and distribution of the Epigenetic
Nov 05, 2021 12:00 pm ET
Sidoti Microcap Virtual Conference
A Conference Open to All Classes of Investors70+ Companies Presenting and Meeting Interested Investors 1x1Wednesday and Thursday, December 8-9, 2021
Oct 26, 2021 07:00 am ET
Mednow Closes Previously Announced Acquisition of Pharmacy in British Columbia
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW; OTCQB:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has completed the acquisition, previously announced on September 22, 2021, of all of the issued and outstanding shares of Mednow Pharmacy Inc. (“Mednow West”), for an aggregate cash payment of approximately $74,000 and the Company’s agreement to convert approximately $908,000 owed by Mednow West to the Company pursuant to a pharmacy agreement dated September 24, 2020, as amended October 30, 2020 (the “Pharmacy Agreement”) int
Oct 21, 2021 07:00 am ET
Mednow Reports Q4 2021 Financial Results and Operational Milestones
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce it has released its financial results for the period ending July 31, 2021 (“Q4 2021”). Mednow’s Financial Statements and Management, Discussion & Analysis are available on sedar.com and on the Company’s website, investo
Oct 07, 2021 07:00 am ET
Mednow Signs Marketing Services Agreement With Sterling Capital Brokers
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has executed a Marketing Services Agreement with Sterling Capital Brokers Ltd. (the “Agreement”)(“Sterling”). The Agreement allows Sterling to market Mednow’s digital pharmacy and healthcare platform to its network of 100,000 plan members.
Sep 28, 2021 07:00 am ET
Mednow Announces Executive Appointments to Accelerate its Institutional Services Business
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has made two executive hires, bolstering its institutional services business which seeks to provide pharmacy and healthcare solutions to employers, insurers, consulting firms, financial advisors and brokers. The Company
Sep 22, 2021 07:00 am ET
Mednow Enters Into Agreement to Acquire a Pharmacy in British Columbia
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW; OTCQB:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has entered into a share purchase agreement (the “Share Purchase Agreement”) on September 22, 2021 with Mednow Pharmacy Inc. (“Mednow West”) and the shareholders of Mednow West, pursuant to which the Company shall acquire all of the issued and outstanding shares (the “Shares”) of Mednow West, in consideration for an aggregate cash payment of approximately $74,000 and the Company’s agreement to convert approximately $90
Sep 15, 2021 07:00 am ET
Mednow Launches Mednow Virtual Care
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company has launched Mednow Virtual Care, a proprietary platform to provide telemedicine services to Mednow clients. Mednow Virtual Care can be accessed online through the following link: Mednow Virtual Care.
Sep 13, 2021 07:00 am ET
Mednow to Present at the Virtual Gravitas Health Reimagined Investor Day
Mednow Inc. (“Mednow” or the “Company”) (TSXV: MNOW) (OTCQB: MDNWF) , Canada’s on-demand virtual pharmacy, is pleased to announce it will be participating in the Virtual Gravitas Health Reimagined Investor Day taking place Thursday, September 16th, 2021 virtually.
Sep 10, 2021 07:00 am ET
Mednow Commences Operation in Nova Scotia
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW; OTCQB:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce it has received all necessary approvals for its pharmacy license from the Nova Scotia College of Pharmacists to expand its pharmacy operations in the province of Nova Scotia. With operations in Nova Scotia now established for on-demand home delivery services, Mednow.ca services Halifax, the largest city in Atlantic Canada, with same-day delivery. The Company now offers its digital pharmacy services through three fulfillment centres located in Ontario, Brit
Aug 17, 2021 08:00 am ET
PHARMACARE: If Medication Is Provided, Will Canadians Take Them?
Attention news, assignment, health, politics, business editors and reporters:
Aug 11, 2021 07:00 am ET
Mednow to Present at the SNN Network Summer Virtual Event and Sidoti Microcap Conference
Mednow Inc. (TSXV: MNOW) (“Mednow” or the “Company”), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be attending both the SNN Network Summer Virtual Event and the Sidoti Microcap Conference on August 18 and 19, 2021. Mednow will be represented at the investor conferences by Karim Nassar, Founder and CEO, Ali Reyhany, Founder and President, and Benjamin Ferdinand, CFO.
Aug 06, 2021 07:00 am ET
Mednow Acquires Medvisit, Canada’s Largest and Longest Standing Doctor Home Visit Provider
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW; OTCQB:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce the Company has acquired 2716725 Ontario Inc. dba Medvisit (“Medvisit”) for $1,320,000 in cash upon closing and a conditional earn-out of up to $680,000, subject to profitability milestones.
Jul 26, 2021 07:00 am ET
Mednow Engages Hybrid for Marketing Services
Mednow Inc. (TSXV: MNOW) (“Mednow” or the “Company”), Canada’s on-demand virtual pharmacy, is pleased to announce that it has retained Hybrid Financial Ltd. (“Hybrid”), an arm’s length party to the Company, to provide marketing services to the Company.
Jul 12, 2021 07:00 am ET
Mednow Invests in Life Support Mental Health Inc. and Signs Non-Binding Letter of Intent to Acquire Complementary Medical Operation
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW; OTCQB:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce the Company has signed an investment agreement (the “Investment Agreement”) to acquire an equity interest in Life Support Mental Health Inc. (“LSMH”). Pursuant to the Investment Agreement, Mednow invested $500,000 for an initial equity interest of 9%. Mednow has agreed to invest an additional aggregate total of $1,000,000 in two separate tranches to potentially bring its equity interest to approximately 18% upon LSMH’s achievement of certain milestones.
Jul 07, 2021 07:00 am ET
Mednow Receives DTC Eligibility and Amends Stock Option Plan
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW, OTCQB:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has received confirmation from The Depository Trust Company (“DTC”) that its common shares (“Common Shares”) are now eligible for electronic clearing and settlement through DTC in the United States. The DTC eligibility will facilitate the trading of the Common Shares on the OTCQB exchange.
Jun 29, 2021 07:00 am ET
Mednow Reports Q3 2021 Financial Results and Provides Update on Strategic Growth Initiatives
Mednow Inc. (the “Company” or “Mednow”) (TSXV:MNOW) today reported financial results for the third quarter ended April 30, 2021.
May 17, 2021 08:57 am ET
Mednow Becomes Preferred Provider to Police Pensioners Association of Ontario; Appoints New CFO
Mednow Inc. (“Mednow” or the “Company”)(TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company has entered into a Preferred Pharmacy Provider Agreement dated May 16, 2021 with the Police Pensioners Association of Ontario (“PPAO”).
May 06, 2021 08:00 am ET
Mednow to Add Nova Scotia Fulfillment Centre in its Pursuit of National Coverage
Mednow Inc. (“Mednow” or the “Company”)(TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company has filed an application for a pharmacy license with the Nova Scotia College of Pharmacists through a wholly-owned subsidiary, Mednow Pharmacy NS Ltd. Upon successful application, this wholly-owned entity will be a licensed pharmacy that will be regulated by Nova Scotia College of Pharmacists as well as provincial and federal regulatory bodies with oversight of pharmacy practices.
May 04, 2021 08:00 am ET
Mednow Establishes Proprietary Telemedicine Service
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company has formed Mednow Virtual Care Ltd. (“Mednow Virtual Care”) to provide its proprietary telemedicine service, allowing Mednow to offer its patients integrated access to doctors. Mednow Virtual Care is expected to launch its services in Ontario in the second quarter of 2021.
May 03, 2021 08:00 am ET
Mednow to Host Webcast on May 4, 2021
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting a webcast investor presentation on Tuesday, May 4, 2021 at 1pm ET.
Apr 14, 2021 01:32 pm ET
Mednow.ca, Canada's Online and Delivery-Based Virtual Pharmacy, CEO Clip Video
Vancouver, British Columbia--(Newsfile Corp. - April 14, 2021) - Mednow.ca (TSXV: MNOW) - CEO of Mednow.ca, Karim Nassar, speaks about the company's online and delivery-based virtual pharmacy.
Apr 07, 2021 07:30 am ET
Mednow Engages Independent Trading Group for Market Making Services
Mednow Inc. (TSXV: MNOW) (“Mednow” or the “Company”), Canada’s on-demand virtual pharmacy, is pleased to announce that it has entered into an agreement with Independent Trading Group (“ITG”), an arm’s length party to the Company, to provide market making services for a period of 3-months with the objective of maintaining a reasonable market and improving the liquidity of its securities.
Apr 06, 2021 09:39 am ET
Mednow Clarifies Brokerage Conducting Normal Course Issuer Bid
Mednow Inc. (TSX-V: MNOW) (“Mednow” or the “Company”), Canada’s on-demand virtual pharmacy, announces that further to its press release dated March 29, 2021, the Company wishes to clarify that purchases under the Company’s Normal Course Issuer Bid will be made from time to time by Gravitas Securities Inc. on behalf of the Company through the facilities of the TSX Venture Exchange.
Mar 29, 2021 01:48 pm ET
Mednow Announces Normal Course Issuer Bid
Mednow Inc. (TSX-V: MNOW) (“Mednow” or the “Company”), Canada’s on-demand virtual pharmacy, is pleased to announce that the TSX Venture Exchange (the “Exchange”) has accepted a notice filed by the Company of its intention to make a Normal Course Issuer Bid (the “Bid”) to be transacted through the facilities of the Exchange.
Mar 26, 2021 06:02 pm ET
Mednow Reports Q2 2021 Financial Results and Operational Milestones
Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce it has released its financial results for the period ending January 31, 2021 (“Q2 2021”). Mednow’s Financial Statements and Management’s Discussion & Analysis are available under the Company’s profile on www.sedar.com and on the Compa
Mar 19, 2021 07:30 am ET
Mednow Advances National Expansion through Manitoba
Mednow Inc. (“Mednow” or the “Company”)(TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce a significant operational milestone in advancing its national expansion strategy. Mednow has filed an application for a pharmacy license with the Manitoba College of Pharmacists through a wholly-owned subsidiary, Mednow Pharmacy MB Ltd. Upon successful application, this wholly-owned entity will be a licensed pharmacy that will be regulated by Manitoba College of Pharmacists as well as provincial and federal regulatory bodies with oversight of pharmacy practices.
Mar 18, 2021 01:39 pm ET
BTV New Listing Alert Video: Mednow.ca - A Full-Service Online Pharmacy
Vancouver, British Columbia--(Newsfile Corp. - March 18, 2021) - Mednow.ca (TSXV: MNOW) - Mednow.ca, Canada's online and delivery based virtual pharmacy, is newly listed on the Toronto Stock Exchange Venture under the symbol MNOW.
Mar 12, 2021 09:48 am ET
Mednow Engages Native Ads for Digital Media Services
Mednow Inc. (TSXV: MNOW) (“Mednow” or the “Company”), Canada’s on-demand virtual pharmacy, is pleased to announce that it has entered into an agreement with Native Ads Inc. (“Native Ads”), an arm’s length party to the Company, to provide a 12-month programmatic digital advertising campaign in connection with the Company’s ongoing effort to increase awareness. This comprehensive advertising program is designed to build brand familiarity, general recognition, and awareness within online investor content platforms. Native Ads will employ state of the art digital advertising,
Mar 09, 2021 11:15 am ET
Mednow Virtually Opens The Market
VANCOUVER, BC, March 9, 2021 /CNW/ - Karim Nassar, Chief Executive Officer & Co-Founder, Mednow Inc. and Ali Reyhany, Co-Founder, Director and President, Mednow Inc. ("Mednow" or the "Company") (TSXV: MNOW), and their team joined Dani Lipkin, Director, Global Business Development, TMX Group, to celebrate the Company's new listing on TSX Venture Exchange and open the market.
Mar 09, 2021 07:30 am ET
Mednow to Begin Trading on TSX Venture Exchange under Ticker Symbol “MNOW” Today and Releases Letter to Shareholders
Mednow Inc. (“Mednow” or the “Company”), Canada’s on-demand virtual pharmacy, is pleased to announce that its common shares will begin trading on the TSX Venture Exchange under the symbol “MNOW” effective today.